India probes cause of 436 clinical trial deaths

A total of 436 Indians lost their lives during clinical trials sponsored in the subcontinent last year, according to government officials. But they are still trying to determine how many of those deaths were directly caused by the drugs they were taking. In 2011, 16 of the 438 deaths recorded were linked to experimental drugs. The year before the tally was 22. Government officials in India have put the clinical trial industry in the spotlight recently, following a number of reports claiming that drug developers were using poor people as "guinea pigs" to test risky therapies. Story

Suggested Articles

Fifteen of the 22 patients in a gene therapy trial no longer needed transfusions, while the remainder needed fewer transfusions.

Argos Therapeutics is ending its kidney cancer trial and mulling options, including a merger or sale, to stay alive.

CNS Pharma says berubicin is the first anthracycline drug to cross the blood-brain barrier and could transform treatment of the highly invasive brain tumor.